TY - JOUR
T1 - Lyme borreliosis in Bell's palsy
AU - Long Island Neuroborreliosis Collaborative Study Group
AU - Halperin, John J.
AU - Golightly, M.
AU - Andriola, M.
AU - Belman, A.
AU - Carnevale, N.
AU - Carvajal, P.
AU - Chacko, M.
AU - Chernik, N.
AU - Coyle, P.
AU - de Lanerolle, S.
AU - Greenwood, J.
AU - Gudesblatt, M.
AU - Kaplan, G.
AU - Moore, R.
AU - Moreta, H.
AU - Mortati, F.
AU - Newman, G.
AU - Pearl, R.
AU - Poole, P.
AU - Reiser, H.
AU - Rosen, A.
AU - Rudansky, M.
AU - Sachs, H.
AU - Sauter, M.
AU - Schroeter, G.
AU - Winter, J.
AU - Zuckerman, M.
PY - 1992/7
Y1 - 1992/7
N2 - Lyme borreliosis (LB) causes a range of neurologic manifestations, the most common of which is facial nerve paralysis. To evaluate nervous system LB, we organized a neurologic collaborative study group in Suffolk County, NY, a region of high LB incidence. Between July and September 1989, LB serologies were performed on all patients with new-onset Bell's palsy. Seven of 32 had serologic evidence of LB at onset. One, initially seronegative, was highly seropositive 5 weeks later. In the five in whom we examined CSF, there was no evidence of intrathecal synthesis of specific antibody. In highly endemic areas, LB may be responsible for 1/4 of cases of Bell's palsy. Rarely, the palsy may occur prior to the development of a measurable antibody response, indicating a need for follow-up serologic testing.
AB - Lyme borreliosis (LB) causes a range of neurologic manifestations, the most common of which is facial nerve paralysis. To evaluate nervous system LB, we organized a neurologic collaborative study group in Suffolk County, NY, a region of high LB incidence. Between July and September 1989, LB serologies were performed on all patients with new-onset Bell's palsy. Seven of 32 had serologic evidence of LB at onset. One, initially seronegative, was highly seropositive 5 weeks later. In the five in whom we examined CSF, there was no evidence of intrathecal synthesis of specific antibody. In highly endemic areas, LB may be responsible for 1/4 of cases of Bell's palsy. Rarely, the palsy may occur prior to the development of a measurable antibody response, indicating a need for follow-up serologic testing.
UR - https://www.scopus.com/pages/publications/0026719188
U2 - 10.1212/wnl.42.7.1268
DO - 10.1212/wnl.42.7.1268
M3 - Article
C2 - 1620330
AN - SCOPUS:0026719188
SN - 0028-3878
VL - 42
SP - 1268
EP - 1270
JO - Neurology
JF - Neurology
IS - 7
ER -